Drug Type Bispecific antibody |
Synonyms ON-06 |
Target |
Action inhibitors |
Mechanism MSLN inhibitors(Mesothelin inhibitors) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Cancer | Discovery | Austria | 21 Mar 2024 | |
Solid tumor | Discovery | Austria | - |